Latest news

BDD Completes Successful Dosing of all Patients, on Schedule, in Head-to-Head Clinical Study of Investigational Subcutaneous Furosemide (SQIN-Furosemide)

Latest blog posts

25 Years of BDD: From Spin-out to Lean Clinical Development™